AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)
Public ClinicalTrials.gov record NCT04895215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of AB-2004 in an Autism Spectrum Disorder Population
Study identification
- NCT ID
- NCT04895215
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vertero Therapeutics
- Industry
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- AB-2004 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2021
- Primary completion
- Nov 14, 2023
- Completion
- Dec 14, 2023
- Last update posted
- Nov 20, 2025
2021 – 2023
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex Neuroscience Research | Dothan | Alabama | 36303 | — |
| Southwestern Autism Research and Resource Center | Phoenix | Arizona | 85006 | — |
| University of Arizona | Tucson | Arizona | 85724 | — |
| Cortica Marin | San Rafael | California | 94903 | — |
| Cortica Westlake | Westlake Village | California | 91361 | — |
| IMMUNOe Research Centers | Centennial | Colorado | 80112 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| CNS Solutions | Jacksonville | Florida | 32256 | — |
| CNS Solutions | Orlando | Florida | 32801 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| Baber Research | Naperville | Illinois | 60563 | — |
| University of Missouri, Thompson Center for Autism and Neurodevelopmental Disorders | Columbia | Missouri | 65201 | — |
| Clinical Research of Southern Nevada | Las Vegas | Nevada | 89128 | — |
| Spectrum Neuroscience and Treatment Institute | New York | New York | 10021 | — |
| Nathan S. Kline Institute for Psychiatric Research | Orangeburg | New York | 10962 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
| Relaro Medical Trials | Dallas | Texas | 75243 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04895215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04895215 live on ClinicalTrials.gov.